Ascelia Pharma (ACE.ST) Stock Price
Ascelia Pharma Price
Ascelia Pharma stock price
Ascelia Pharma business model & stock analysis
Frequently asked questions about Ascelia Pharma
5 analysts currently rate the Ascelia Pharma stock: 4 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Ascelia Pharma to generate revenue of 26.00 M SEK and earnings per share of -0.08 SEK.
Converted at the current exchange rate, the Ascelia Pharma share trades at 0.06 EUR (0.70 SEK).
The expected revenue of Ascelia Pharma is 26.00 M SEK. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Ascelia Pharma is -10.21 M SEK. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Ascelia Pharma is currently -8.70. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Ascelia Pharma stock.
The price-to-sales ratio (P/S) of Ascelia Pharma is currently 3.41. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Ascelia Pharma stock.
The Eulerpool Quality Score for Ascelia Pharma is 2/10.
The ISIN of Ascelia Pharma is SE0010573113. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Ascelia Pharma is A2H81X. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Ascelia Pharma is ACE.ST. The ticker symbol is used to trade Ascelia Pharma shares on the stock exchange.
Ascelia Pharma stock
Ascelia Pharma Peer Group
Ascelia Pharma FIGI
All fundamentals and in-depth analysis of Ascelia Pharma
Our stock analysis for Ascelia Pharma stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Ascelia Pharma. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.